Le Lézard
Classified in: Covid-19 virus
Subject: ATY

Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights - GRTS


NEW YORK, July 1, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Gritstone investors who were adversely affected by alleged securities fraud between March 9, 2023 and February 29, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=88005&wire=4

GRTS investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the Company would be unable to launch the Phase 2b CORAL Study, it's approved COVID-19 vaccine, in the timeframe it had represented to investors; (ii) the foregoing would impair Gritstone's ability to obtain external funding in connection with the Study, thereby negatively affecting Gritstone's ability to maintain its balance sheet and cash position; (iii) accordingly, Gritstone overstated its ability to successfully develop and commercialize its products; (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Gritstone during the relevant time frame, you have until August 6, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 08:15
Masimo , today announced that the Masimo W1® Sport advanced health tracking wearable is gaining a powerful new feature: scientifically based sleep analysis with Sleep Halotm. Sleep Halo offers overnight sleep data tracking with an unmatched 70,000+...

at 08:10
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced $11.8 million private placement to accredited...

at 08:00
Catheter Precision, Inc. a MedTech company pioneering products in the growing field of cardiac electrophysiology, including its VIVO™ and LockeT product(s), releases Q2 Revenue for the quarter ending June 30, 2024.Catheter Precision, Inc....

at 07:25
The "mRNA Synthesis and Manufacturing Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area, Therapeutic Area and Key Geographical Regions" report has been added to ResearchAndMarkets.com's...

at 06:32
The green energy transition is driving global decarbonization efforts, especially in hard-to-abate industries, boosting the importance of hydrogen and its low-carbon forms. This surge is set to propel the hydrogen storage materials market to $7.7...

at 06:05
Healthcare Trust, Inc. ("HTI") announced today that, in anticipation of a potential future listing of HTI's common stock on a national securities exchange, it has provided notice to Healthcare Trust Advisors, LLC (the "Advisor"), the external...



News published on and distributed by: